MedTrace Logo

Observational Study Linking Genetic Variants With Clinical Outcomes in Pain Management

NCT02480075 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2016-03-30

No results posted yet for this study

Summary

The purpose of this study is to (a) evaluate the treatment approaches and changes in treatment regimens utilized by clinicians when genetic testing is performed in the clinic; and (b) create a patient data registry to identify genetic factors that influence treatment outcomes in pain management.

Conditions

Interventions

OTHER

Observational

Observational Study only

Sponsors & Collaborators

  • University of Southern California

    collaborator OTHER

  • Proove Bioscience, Inc.

    lead INDUSTRY

Principal Investigators

  • Steven Richeimer, M.D. · University of Southern California

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2020-06-30
Completion
2020-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02480075 on ClinicalTrials.gov